Analyst Activity – William Blair Initiates Coverage On Aileron Therap (NASDAQ:ALRN) With a Outperform

Analyst Ratings For Aileron Therap (NASDAQ:ALRN)

Story continues below

Today, William Blair initiated coverage on Aileron Therap (NASDAQ:ALRN) with a Outperform .

There are 4 buy ratings on the stock.

The current consensus rating on Aileron Therap (NASDAQ:ALRN) is Buy (Score: 3.00) with a consensus target price of $19.33 per share, a potential 53.44% upside.

Some recent analyst ratings include

  • 7/24/2017-William Blair initiated coverage with a Outperform rating.
  • 7/24/2017-Bank of America Corporation initiated coverage with a Buy rating.
  • 7/24/2017-Canaccord Genuity initiated coverage with a Buy rating.
  • 7/24/2017-Jefferies Group LLC initiated coverage with a Buy rating.

    Recent Trading Activity for Aileron Therap (NASDAQ:ALRN)
    Shares of Aileron Therap closed the previous trading session at 12.60 down -0.18 -1.41% with 194,875 shares trading hands.

    An ad to help with our costs